+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Swine Epidemic Encephalitis Inactivated Vaccine Market by Animal Classification (Boar, Piglet, Sow), Vaccine Type (Attenuated Vaccine, Inactivated Vaccine), Dosage Form, Packaging Size, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Swine Epidemic Encephalitis Inactivated Vaccine Market by Animal Classification (Boar, Piglet, Sow), Vaccine Type (Attenuated Vaccine, Inactivated Vaccine), Dosage Form, Packaging Size, End User, Distribution Channel - Global Forecast 2025-2030- Product Image
Sale

Swine Epidemic Encephalitis Inactivated Vaccine Market by Animal Classification (Boar, Piglet, Sow), Vaccine Type (Attenuated Vaccine, Inactivated Vaccine), Dosage Form, Packaging Size, End User, Distribution Channel - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 185 Pages
  • August 2025
  • Region: Global
  • 360iResearch™
  • ID: 6082031
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The swine epidemic encephalitis inactivated vaccine market is undergoing strategic transformation as animal health players adapt to advances in immunology, evolving animal segmentation, and dynamic global trade conditions. This up-to-date executive summary delivers actionable insights designed for senior stakeholders, guiding optimal decisions in a shifting regulatory and commercial landscape.

Market Snapshot: Swine Epidemic Encephalitis Inactivated Vaccine Market

The swine epidemic encephalitis inactivated vaccine market is positioned at the intersection of biotechnology innovation and global swine health priorities. Rising awareness of neurological viral risks among porcine herds, bolstered by ongoing research and regulatory shifts, drives both vaccine development and adoption. The sector is adapting to changes in raw material supply, advanced manufacturing, and diversified sales models, making it essential for decision-makers to align operational responses with this evolving competitive environment. Market size, growth rate, and projected CAGR are [data unavailable].

Scope & Segmentation

This comprehensive analysis examines all critical aspects shaping the swine epidemic encephalitis inactivated vaccine market.

  • Animal Classifications: Boars for breeding, piglets segmented as suckling, weaned, and grower-finisher groups, and sows differentiated as gilts and mature females for targeted immunization protocols.
  • Vaccine Types: Attenuated vaccines utilized in research contexts and a primary focus on inactivated vaccines, including subunit inactivated and whole pathogen inactivated solutions for broadscale application.
  • Dosage Forms: Both liquid suspension and lyophilized powder, balancing on-farm administration efficiency with shelf life and cold chain logistics.
  • Packaging Sizes: Multi dose vials preferred for commercial farm campaigns and single dose vials aligning with research institutions and veterinary clinic requirements.
  • End Users: Commercial swine farms, veterinary clinics, and specialized research institutions guiding distinct procurement and use patterns.
  • Distribution Channels: Direct sales, distributors, e-commerce platforms, manufacturer websites, and third-party retailers enabling adaptable go-to-market strategies.
  • Region Focus: Americas (with country-level detail), Europe, Middle East & Africa, and Asia-Pacific. Delivery strategies are tailored to the infrastructure, regulatory context, and animal health priorities in each region.
  • Key Industry Players: Analysis of current initiatives and innovations from Hualan Biological Engineering Inc., Harbin Weitong Biological Product Co., Ltd., Liaoning Chengda Biological Co., Ltd., Shandong YEBIO Bioengineering Co., Ltd., Anhui Dahuanong Biotechnology Co., Ltd., Boehringer Ingelheim Animal Health GmbH, Ceva Santé Animale (International) S.A., Zoetis Inc., Merck & Co., Inc. (Merck Animal Health), and Elanco Animal Health Incorporated.

Key Takeaways for Senior Stakeholders

  • Technology advancements in antigen preparation, adjuvant systems, and continuous manufacturing contribute to higher vaccine stability and adaptation to diverse field conditions.
  • Operational innovations—such as single-use bioreactors and digital integration of supply chains—accelerate production scalability while limiting contamination and batch changeover risks.
  • Strategic segmentation by animal class, dosage form, and packaging allows precise vaccine delivery, optimizing maternal antibody transfer and herd protection across commercial, research, and clinical use cases.
  • Online sales and e-commerce portals increase access for clinics and smallholder farms, especially in regions with underdeveloped traditional distribution channels or facing trade policy barriers.
  • Collaborative ventures, co-manufacturing, and technology transfer agreements are effective in mitigating the volatility of sourcing and trade policies, building supply resilience and expanding market reach.
  • Regulatory engagement promotes faster product approvals, harmonized compliance, and clearer routes to market entry across varied international frameworks.

Tariff Impact on Vaccine Supply and Pricing

Recent U.S. tariff changes in 2025 have increased the cost of key vaccine inputs, pressuring margins, and prompting a shift toward nearshoring and localized sourcing strategies. Supply chain partners are reevaluating inventory, margin, and stocking approaches, while digital sales platforms provide access stability amid tariff volatility. Strategic collaborations, including joint ventures and technology transfer, help stakeholders distribute risks and resources under evolving policy constraints.

Methodology & Data Sources

Insights in this report are drawn from primary interviews with vaccine developers, regulatory authorities, and veterinary professionals; validated through secondary research across peer-reviewed publications, policy documents, and industry white papers. Detailed segmentation and regional analyses are supported by field surveys, clinical trial data, procurement records, and supply chain performance metrics.

Why This Report Matters

  • Enables data-driven investment, production, and market access strategies tailored to evolving animal health and global trade dynamics.
  • Equips senior leaders with granular, actionable intelligence to optimize segmentation, innovate distribution, and fortify competitive positioning.
  • Assists in identifying collaborative and technological pathways for risk management and regulatory navigation at scale.

Conclusion

By leveraging this in-depth analysis, industry stakeholders gain the strategic context necessary to adapt, invest, and lead across the global swine epidemic encephalitis inactivated vaccine market. Continued innovation, targeted partnerships, and market agility will define sustainable leadership moving forward.



This product will be delivered within 1-3 business days.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
5.1. Shift towards recombinant adjuvant formulations to enhance immune response in swine epidemic encephalitis vaccines
5.2. Expansion of government-led mass vaccination initiatives to curb swine epidemic encephalitis outbreaks in Asia-Pacific regions
5.3. Implementation of cold chain optimization technologies to maintain potency of inactivated swine encephalitis vaccines
5.4. Increasing investments in scalable bioreactor production processes for inactivated swine encephalitis vaccines
5.5. Integration of real-time epidemiological surveillance with vaccine deployment strategies to preempt swine encephalitis outbreaks
5.6. Strategic partnerships between biotech firms and animal health authorities to accelerate vaccine approval timelines
5.7. Adoption of digital traceability solutions to monitor vaccine quality and distribution in swine production chains
5.8. Growing demand for cost-effective multivalent vaccines combining swine encephalitis and other prevalent diseases
5.9. Emergence of novel thermostable vaccine formulations reducing dependence on cold chain logistics in rural farms
5.10. Rise of cross-border regulatory harmonization efforts to expedite market access for swine encephalitis vaccines
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Animal Classification
8.1. Introduction
8.2. Boar
8.3. Piglet
8.3.1. Grower Finisher Piglet
8.3.2. Suckling Piglet
8.3.3. Weaned Piglet
8.4. Sow
8.4.1. Gilt
8.4.2. Mature Sow
9. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Vaccine Type
9.1. Introduction
9.2. Attenuated Vaccine
9.3. Inactivated Vaccine
9.3.1. Subunit Inactivated
9.3.2. Whole Pathogen Inactivated
10. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Dosage Form
10.1. Introduction
10.2. Liquid Suspension
10.3. Lyophilized Powder
11. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Packaging Size
11.1. Introduction
11.2. Multi Dose Vial
11.3. Single Dose Vial
12. Swine Epidemic Encephalitis Inactivated Vaccine Market, by End User
12.1. Introduction
12.2. Commercial Swine Farm
12.3. Research Institution
12.4. Veterinary Clinic
13. Swine Epidemic Encephalitis Inactivated Vaccine Market, by Distribution Channel
13.1. Introduction
13.2. Direct Sales
13.3. Distributors
13.4. Online Sales
13.4.1. E Commerce Platform
13.4.2. Manufacturer Website
13.5. Third Party Retailers
14. Americas Swine Epidemic Encephalitis Inactivated Vaccine Market
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. Argentina
15. Europe, Middle East & Africa Swine Epidemic Encephalitis Inactivated Vaccine Market
15.1. Introduction
15.2. United Kingdom
15.3. Germany
15.4. France
15.5. Russia
15.6. Italy
15.7. Spain
15.8. United Arab Emirates
15.9. Saudi Arabia
15.10. South Africa
15.11. Denmark
15.12. Netherlands
15.13. Qatar
15.14. Finland
15.15. Sweden
15.16. Nigeria
15.17. Egypt
15.18. Turkey
15.19. Israel
15.20. Norway
15.21. Poland
15.22. Switzerland
16. Asia-Pacific Swine Epidemic Encephalitis Inactivated Vaccine Market
16.1. Introduction
16.2. China
16.3. India
16.4. Japan
16.5. Australia
16.6. South Korea
16.7. Indonesia
16.8. Thailand
16.9. Philippines
16.10. Malaysia
16.11. Singapore
16.12. Vietnam
16.13. Taiwan
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Hualan Biological Engineering Inc.
17.3.2. Harbin Weitong Biological Product Co., Ltd.
17.3.3. Liaoning Chengda Biological Co., Ltd.
17.3.4. Shandong YEBIO Bioengineering Co., Ltd.
17.3.5. Anhui Dahuanong Biotechnology Co., Ltd.
17.3.6. Boehringer Ingelheim Animal Health GmbH
17.3.7. Ceva Santé Animale (International) S.A.
17.3.8. Zoetis Inc.
17.3.9. Merck & Co., Inc., d/b/a Merck Animal Health
17.3.10. Elanco Animal Health Incorporated
18. Research AI19. Research Statistics20. Research Contacts21. Research Articles22. Appendix
List of Figures
FIGURE 1. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET RESEARCH PROCESS
FIGURE 2. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 3. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 4. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2024 VS 2030 (%)
FIGURE 6. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET, FPNV POSITIONING MATRIX, 2024
FIGURE 27. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET: RESEARCHAI
FIGURE 28. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET: RESEARCHSTATISTICS
FIGURE 29. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET: RESEARCHCONTACTS
FIGURE 30. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET: RESEARCHARTICLES
List of Tables
TABLE 1. SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, 2018-2024 (USD MILLION)
TABLE 4. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, 2025-2030 (USD MILLION)
TABLE 5. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY REGION, 2018-2024 (USD MILLION)
TABLE 6. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY REGION, 2025-2030 (USD MILLION)
TABLE 7. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 8. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 9. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 10. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 11. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY BOAR, BY REGION, 2018-2024 (USD MILLION)
TABLE 12. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY BOAR, BY REGION, 2025-2030 (USD MILLION)
TABLE 13. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 14. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 15. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY GROWER FINISHER PIGLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 16. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY GROWER FINISHER PIGLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 17. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SUCKLING PIGLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 18. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SUCKLING PIGLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 19. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY WEANED PIGLET, BY REGION, 2018-2024 (USD MILLION)
TABLE 20. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY WEANED PIGLET, BY REGION, 2025-2030 (USD MILLION)
TABLE 21. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 22. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 23. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 24. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 25. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY GILT, BY REGION, 2018-2024 (USD MILLION)
TABLE 26. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY GILT, BY REGION, 2025-2030 (USD MILLION)
TABLE 27. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MATURE SOW, BY REGION, 2018-2024 (USD MILLION)
TABLE 28. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MATURE SOW, BY REGION, 2025-2030 (USD MILLION)
TABLE 29. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 30. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 31. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 32. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 33. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 34. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ATTENUATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 35. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2018-2024 (USD MILLION)
TABLE 36. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, BY REGION, 2025-2030 (USD MILLION)
TABLE 37. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SUBUNIT INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 38. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SUBUNIT INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 39. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY WHOLE PATHOGEN INACTIVATED, BY REGION, 2018-2024 (USD MILLION)
TABLE 40. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY WHOLE PATHOGEN INACTIVATED, BY REGION, 2025-2030 (USD MILLION)
TABLE 41. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 42. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 43. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 44. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 45. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY LIQUID SUSPENSION, BY REGION, 2018-2024 (USD MILLION)
TABLE 46. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY LIQUID SUSPENSION, BY REGION, 2025-2030 (USD MILLION)
TABLE 47. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2018-2024 (USD MILLION)
TABLE 48. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY LYOPHILIZED POWDER, BY REGION, 2025-2030 (USD MILLION)
TABLE 49. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 50. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 51. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 52. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MULTI DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 53. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2018-2024 (USD MILLION)
TABLE 54. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SINGLE DOSE VIAL, BY REGION, 2025-2030 (USD MILLION)
TABLE 55. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 56. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 57. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COMMERCIAL SWINE FARM, BY REGION, 2018-2024 (USD MILLION)
TABLE 58. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COMMERCIAL SWINE FARM, BY REGION, 2025-2030 (USD MILLION)
TABLE 59. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY RESEARCH INSTITUTION, BY REGION, 2018-2024 (USD MILLION)
TABLE 60. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY RESEARCH INSTITUTION, BY REGION, 2025-2030 (USD MILLION)
TABLE 61. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2018-2024 (USD MILLION)
TABLE 62. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VETERINARY CLINIC, BY REGION, 2025-2030 (USD MILLION)
TABLE 63. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 64. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 65. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 66. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DIRECT SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 67. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2018-2024 (USD MILLION)
TABLE 68. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTORS, BY REGION, 2025-2030 (USD MILLION)
TABLE 69. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, BY REGION, 2018-2024 (USD MILLION)
TABLE 70. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, BY REGION, 2025-2030 (USD MILLION)
TABLE 71. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2018-2024 (USD MILLION)
TABLE 72. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY E COMMERCE PLATFORM, BY REGION, 2025-2030 (USD MILLION)
TABLE 73. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2018-2024 (USD MILLION)
TABLE 74. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY MANUFACTURER WEBSITE, BY REGION, 2025-2030 (USD MILLION)
TABLE 75. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 76. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 77. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY THIRD PARTY RETAILERS, BY REGION, 2018-2024 (USD MILLION)
TABLE 78. GLOBAL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY THIRD PARTY RETAILERS, BY REGION, 2025-2030 (USD MILLION)
TABLE 79. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 80. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 81. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 82. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 83. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 84. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 85. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 86. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 87. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 88. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 89. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 90. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 91. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 92. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 93. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 94. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 95. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 96. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 97. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 98. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 99. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 100. AMERICAS SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 101. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 102. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 103. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 104. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 105. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 106. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 107. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 108. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 109. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 110. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 111. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 112. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 113. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 114. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 115. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 116. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 117. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 118. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 119. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 120. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 121. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2018-2024 (USD MILLION)
TABLE 122. UNITED STATES SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY STATE, 2025-2030 (USD MILLION)
TABLE 123. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 124. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 125. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 126. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 127. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 128. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 129. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 130. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 131. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 132. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 133. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 134. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 135. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 136. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 137. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 138. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 139. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 140. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 141. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 142. CANADA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 143. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 144. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 145. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 146. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 147. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 148. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 149. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 150. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 151. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 152. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 153. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 154. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 155. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 156. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 157. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 158. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 159. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 160. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 161. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 162. MEXICO SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 163. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 164. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 165. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 166. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 167. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 168. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 169. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 170. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 171. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 172. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 173. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 174. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 175. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 176. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 177. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 178. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 179. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 180. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 181. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 182. BRAZIL SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 183. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 184. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 185. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 186. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 187. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 188. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 189. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 190. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 191. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 192. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 193. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 194. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 195. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 196. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 197. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 198. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 199. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 200. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 201. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 202. ARGENTINA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 203. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 204. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 205. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 206. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 217. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 218. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 219. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 220. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 221. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 222. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 223. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2018-2024 (USD MILLION)
TABLE 224. EUROPE, MIDDLE EAST & AFRICA SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY COUNTRY, 2025-2030 (USD MILLION)
TABLE 225. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 226. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 227. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 228. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 229. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 230. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 232. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 234. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 236. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 237. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 238. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 239. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 240. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 241. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLION)
TABLE 242. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025-2030 (USD MILLION)
TABLE 243. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2018-2024 (USD MILLION)
TABLE 244. UNITED KINGDOM SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ONLINE SALES, 2025-2030 (USD MILLION)
TABLE 245. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2018-2024 (USD MILLION)
TABLE 246. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY ANIMAL CLASSIFICATION, 2025-2030 (USD MILLION)
TABLE 247. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2018-2024 (USD MILLION)
TABLE 248. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PIGLET, 2025-2030 (USD MILLION)
TABLE 249. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2018-2024 (USD MILLION)
TABLE 250. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY SOW, 2025-2030 (USD MILLION)
TABLE 251. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2018-2024 (USD MILLION)
TABLE 252. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY VACCINE TYPE, 2025-2030 (USD MILLION)
TABLE 253. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2018-2024 (USD MILLION)
TABLE 254. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY INACTIVATED VACCINE, 2025-2030 (USD MILLION)
TABLE 255. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2018-2024 (USD MILLION)
TABLE 256. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DOSAGE FORM, 2025-2030 (USD MILLION)
TABLE 257. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2018-2024 (USD MILLION)
TABLE 258. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY PACKAGING SIZE, 2025-2030 (USD MILLION)
TABLE 259. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
TABLE 260. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY END USER, 2025-2030 (USD MILLION)
TABLE 261. GERMANY SWINE EPIDEMIC ENCEPHALITIS INACTIVATED VACCINE MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2024 (USD MILLIO

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Swine Epidemic Encephalitis Inactivated Vaccine market report include:
  • Hualan Biological Engineering Inc.
  • Harbin Weitong Biological Product Co., Ltd.
  • Liaoning Chengda Biological Co., Ltd.
  • Shandong YEBIO Bioengineering Co., Ltd.
  • Anhui Dahuanong Biotechnology Co., Ltd.
  • Boehringer Ingelheim Animal Health GmbH
  • Ceva Santé Animale (International) S.A.
  • Zoetis Inc.
  • Merck & Co., Inc., d/b/a Merck Animal Health
  • Elanco Animal Health Incorporated

Related Topics

Related Reports

Porcine Epidemic Diarrhea Vaccines Market Report 2025 - Product Image

Porcine Epidemic Diarrhea Vaccines Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Swine Flu Vaccination Market Report 2025 - Product Image

Swine Flu Vaccination Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030 - Product Image

Porcine Vaccines Market by Vaccine Type (Inactivated, Live Attenuated, MRNA), Disease Indication (Classical Swine Fever, Erysipelas, Porcine Reproductive and Respiratory Syndrome), End User, Route Of Administration, Technology, Dosage Form - Global Forecast 2025-2030

  • Report
  • 199 Pages
  • Global
From
Porcine Vaccines - Global Strategic Business Report - Product Image

Porcine Vaccines - Global Strategic Business Report

  • Report
  • 376 Pages
  • Global
From
Inactivated Vaccines - Global Strategic Business Report - Product Image

Inactivated Vaccines - Global Strategic Business Report

  • Report
  • 468 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.